Bone Broth Protein Market Size & Share 2026-2035

Bone Broth Protein Market Size

The global bone broth protein market was valued at USD 93.5 million in 2025 and is poised to reach USD 102.1 million in 2026. It is projected to reach USD 225 million by 2035, advancing at a CAGR of approximately 9.2% from 2026 to 2035.

Growth rests on the conversion of bone-derived broth from a culinary product into a shelf-stable protein and collagen ingredient used in supplements, sports nutrition, functional foods, and pet products.

The category's commercial logic is tied to its raw-material and processing model. Bones are largely sourced from livestock-processing streams, while concentration, extraction, and drying determine whether the output can be sold as a broth, powder, paste, or encapsulated supplement. That structure gives brands a usable circularity narrative, but it also means premium claims such as grass-fed, organic, regenerative, or traceable are procurement decisions with real cost consequences. Essentia Proteins offers OmniBroth in organic and conventional powder and paste formats for food, beverage, and supplement formulators, while Taranaki Bio Extracts supplies traceable New Zealand bovine broth and collagen ingredients. ^{[1]Essentia Proteins, OmniBroth and Bone Broth Ingredients, essentiaproteins.com}

Regulation shapes the route to market rather than creating a single global compliance pathway. In the U.S. dietary-supplement manufacturers remain responsible for safety, labeling, and current good manufacturing practice compliance. ^{[2]Council for Responsible Nutrition (CRN USA), Food and Dietary Supplement Regulations Compared, crnusa.org} In Europe, novel-food status depends on the ingredient and process; the European Commission's catalogue is therefore particularly relevant when a traditional broth is converted into a more novel, concentrated ingredient format. Bovine-derived collagen and gelatin also face a specific animal-health evidence base in Europe. The practical consequence is that companies cannot assume a culinary history will support every concentrated peptide, health-claim, or cross-border product proposition.

Powder remains commercially advantaged because it is shelf-stable, transport-efficient, and readily incorporated into both drinks and food formulations. Liquids trade those operating advantages for immediate consumption and a higher packaging burden. This difference is central to the market's future: category expansion depends on increasing consumption occasions without eroding the margins needed to fund ingredient verification, testing, and branded distribution.

North America provides the largest immediate revenue pool, but the faster projected growth in Asia Pacific changes the allocation question for suppliers and branded companies. Ingredient traceability, claim compliance, and product format will matter more than simply adding another broth SKU: in mature markets they support premiumization, while in developing markets they determine whether imported or locally formulated products can achieve repeat purchase.

Key Drivers

Rising consumer interest in collagen-rich functional nutrition

Bone broth protein benefits when consumers seek a protein format associated with connective-tissue and recovery uses rather than protein quantity alone. In a randomized controlled trial, specific collagen peptides reduced several measures of lower-extremity discomfort after 12 weeks of use. ^{[3]MDPI, International Journal of Environmental Research and Public Health, Impact of Specific Bioactive Collagen Peptides on Joint Discomforts in the Lower Extremity during Daily Activities: A Randomized Controlled Trial, 2024, mdpi.com} Separate research evaluated collagen peptides in exercise-induced muscle damage and recovery settings. These findings do not establish equivalent performance for every bone broth product, but they give formulators a scientific frame for products positioned around collagen-containing nutrition rather than generic protein supplementation.

That distinction is commercially useful because it allows a single ingredient platform to address supplement, active-lifestyle, and savory-food occasions. However, the proposition is only durable where ingredient concentration and labeling are credible. Comparative testing of bone-broth products reported substantial variation in collagen content, making verification a competitive requirement rather than a back-office quality task. ^{[4]ConsumerLab, Best Bone Broths? ConsumerLab Shows How Much Collagen Is Really in Bone Broths, April 2025, consumerlab.com}

Increasing adoption of paleo and keto lifestyles

Paleo- and keto-oriented consumers offer an unusually direct fit for animal-derived, low-carbohydrate, dairy-free protein formats. NielsenIQ-referenced data released by the Paleo Diet Foundation reported 45 million U.S. households buying paleo-labeled products, with household penetration of 35.1%. ^{[5]The Paleo Diet Foundation, The Paleo Diet: The Fastest Growing Movement, February 2025, thepaleodiet.com} For bone broth brands, that installed consumer base lowers education costs: compatibility language can convert shoppers who already use dietary rules to screen ingredients.

Kettle & Fire illustrates why lifestyle alignment has commercial value only when backed by distribution and format. Forbes reported that the company had built annual revenue above USD 100 million, supported by expansion across retail and direct consumer touchpoints. ^{[6]Forbes, How Kettle & Fire Turned Bone Broth Into a $100 Million Business, March 2025, forbes.com} Lifestyle claims can bring discovery, but flavored powders, shelf-stable broths, and convenient packs are what turn a dietary identity into repeatable consumption.

Demand for dairy-free protein alternatives

Bone broth protein occupies a narrow but relevant position between whey and plant proteins. Lactose malabsorption affects a large share of the global population, according to the U.S. National Library of Medicine. For consumers who avoid dairy but do not follow vegetarian or vegan diets, bone broth offers an animal-derived alternative without whey. Its amino-acid composition and broth-like flavor also make it easier to position in savory food applications than many sweetened dairy protein powders.

The addressable opportunity should not be overstated. Plant-based alternatives retain broad consumer appeal, and the Good Food Institute reports continuing activity across plant-based meat, dairy, and ingredient categories. Bone broth protein's advantage is therefore not universal substitution; it is a differentiated option for consumers who value animal sourcing, dairy avoidance, and a collagen-oriented product story at the same time.

Key Restraints

High production and sourcing costs

Premium bone broth protein is not a simple commodity-protein proposition. Traceable animal inputs, long extraction cycles, concentration, drying, and testing all add cost before a brand absorbs packaging and distribution. Taranaki Bio Extracts' positioning around grass-fed New Zealand bovine inputs, traceability, and audited supply arrangements demonstrates the sort of controls that support a premium ingredient proposition, but also the operational specifications behind it.

Cost pressure is particularly pronounced in liquid products, where aseptic processing or refrigerated distribution is needed to preserve convenience. The result is a structural split: powder can pursue broader distribution with favorable logistics, while RTD products must earn enough price realization to offset their heavier operating model. Quality variation identified in independent product testing further raises the cost of credible participation for smaller brands.

Limited appeal among vegetarian and vegan consumers

Animal-bone origin is a firm boundary, not a positioning issue that marketing can solve. Alternative-protein innovation continues to serve consumers who reject animal-derived products, and that segment will not become available to bone broth brands through better flavoring or packaging. The constraint is most consequential in markets and channels where plant-based diets have strong cultural and retail presence.

This ceiling can nevertheless sharpen strategy. Companies that try to compete head-to-head with vegan protein brands risk obscuring their differentiated proposition. The more defensible route is to focus on dairy-free consumers who still accept animal-derived nutrition, and to support the associated collagen, provenance, and formulation claims with product-specific evidence.

The dairy-free proposition is also conditional. It provides a credible bridge away from whey for animal-protein consumers, but it cannot neutralize the vegetarian and vegan exclusion. Brands that articulate this boundary clearly can concentrate investment on their most compatible consumer cohorts instead of spending to chase a structurally unavailable audience.

Bone Broth Protein Market Segment Analysis

By Source

Chicken is the largest source segment, at USD 36.7 million and 39.2% of the market in 2025, and is projected to reach USD 84.2 million by 2035. Its scale reflects broad poultry availability and a comparatively flexible flavor profile, which helps brands use it in both savory broth and flavored powder formats. Beef follows at USD 30.3 million in 2025 and USD 69.1 million in 2035. Beef is more closely tied to grass-fed, regenerative, and ancestral-nutrition positioning, making it a premium-source proposition as much as a protein choice.

Turkey grows from USD 11.7 million to USD 30.4 million, and fish grows from USD 7.6 million to USD 19.8 million over the period. These smaller sources matter because they create room for specialization: turkey broadens the poultry proposition, while fish can connect the category to marine-collagen and beauty-oriented demand. Pork rises from USD 5.1 million to USD 13.7 million, while other sources rise from USD 2.2 million to USD 7.9 million. Source diversification can reduce direct chicken-and-beef competition, although every novel source adds its own procurement, sensory, and regulatory considerations.

By Nature

Conventional product retains scale, rising from USD 60.3 million in 2025 to USD 141.1 million in 2035, because it can draw on broader supply pools and support less expensive retail propositions. Organic product expands from USD 33.2 million to USD 83.9 million and increases its share from 35.5% to 37.3%. The shift signals that premium certification is gaining relevance without displacing the mainstream base.

The commercial implication is a two-tier market rather than a single clean-label premium. Organic brands need a sufficiently strong provenance story to justify input and certification costs; conventional suppliers retain an opportunity where functionality and affordability take precedence. Ingredient suppliers able to offer both options, such as Essentia Proteins, can support brands across that divide.

By Form

Powder rises from USD 58.7 million in 2025 to USD 137.9 million in 2035, preserving category leadership because it combines shelf life, shipping efficiency, portion control, and formulation versatility. Liquid/RTD grows from USD 27.4 million to USD 67.95 million, increasing share from 29.3% to 30.2%. Its appeal is immediate consumption, but its economics remain more exposed to packaging and distribution requirements. Capsules and tablets expand from USD 7.4 million to USD 19.1 million, serving shoppers who approach broth protein as a conventional supplement format.

Format therefore determines more than convenience. Powders are the operational base for scalable distribution, RTD is an occasion-expansion tool, and capsules can enter pharmacy-led joint-health or wellness consideration sets. Ancient Nutrition's savory and soup-inspired Bone Broth Protein launches show how powder can also reach beyond the standard shake format. ^{[7]WholeFoods Magazine, Ancient Nutrition Launches New Soup-Inspired Flavors in Bone Broth Protein Line, September 2023, wholefoodsmagazine.com}

By Application

Dietary supplements remain the largest application, advancing from USD 41.1 million in 2025 to USD 93.6 million in 2035. Sports nutrition rises from USD 30.2 million to USD 68.6 million, where the category's connective-tissue and recovery narrative can complement, rather than replace, conventional muscle-protein products. The underlying evidence base on collagen peptides is relevant here, but brand claims must remain aligned with the specific ingredient and jurisdiction.

Food & beverages is the fastest-expanding application, growing from USD 11.8 million to USD 32.2 million. This is strategically significant because ingredient inclusion in soups, sauces, bars, and functional beverages can reach consumers who do not identify as supplement buyers. Pet food increases from USD 7.2 million to USD 19.1 million, and other uses rise from USD 3.3 million to USD 11.5 million, widening the category's potential while demanding application-specific safety and formulation discipline.

By Distribution Channel

Supermarkets and hypermarkets remain the largest route to market, increasing from USD 30.8 million to USD 71.1 million. Online retail and e-commerce follows, from USD 25.9 million to USD 60.3 million, because it supports education, subscriptions, and assortment breadth. Health and specialty stores grow from USD 19.6 million to USD 45.9 million, preserving their role in premium discovery. Pharmacies and drug stores rise from USD 9.2 million to USD 24.3 million, D2C from USD 7.2 million to USD 18.9 million, and convenience stores from USD 0.7 million to USD 4.5 million.

The small convenience-store base should be interpreted carefully. Its projected growth reflects an early-stage route for portable RTD and single-serve products, not an immediate substitute for supermarket or online scale. Brands that use e-commerce to establish repeat behavior can then make retail expansion less risky; those relying on retail alone face a higher need for shelf productivity and promotional support.

The growing organic share and the faster expansion of smaller source categories indicate that differentiation will increasingly sit in sourcing and application fit. Yet these premiums are viable only when traceability, sensory performance, and product composition remain credible. In practice, the best segment opportunities are likely to be those where premium provenance and functional formulation reinforce each other rather than compete for the same price point.

Bone Broth Protein Market Regional Analysis

North America

North America is the largest regional market, increasing from USD 38.7 million in 2025 to USD 90.0 million in 2035. The U.S. contributes USD 32.5 million in 2025 and is projected to reach USD 75.7 million. The region combines mature supplement retail, direct-to-consumer adoption, and lifestyle-diet demand with an established set of specialized brands. Kettle & Fire's expansion across retail outlets illustrates the importance of distribution depth in turning a niche functional proposition into a mainstream packaged-food purchase.

Europe

Europe grows from USD 25.8 million in 2025 to USD 62.0 million in 2035. Its opportunity is shaped by consumers' interest in organic and clean-label products, but its compliance burden can be more exacting for concentrated and claim-led formats. Novel-food status and bovine-source controls require product-specific review rather than a blanket assumption based on traditional broth history. This favors suppliers able to provide clear ingredient documentation to branded customers.

Asia Pacific

Asia Pacific is projected to grow fastest, from USD 19.4 million in 2025 to USD 60.0 million in 2035. The region's poultry familiarity, established collagen consumption in several markets, and digital-commerce reach create a favorable setting for both chicken-based products and imported premium propositions. Growth will not be uniform: local food traditions can help consumer relevance, but local claim rules, landed costs, and channel fragmentation make a replicated North American go-to-market model unreliable.

Latin America

Latin America advances from USD 6.4 million in 2025 to USD 13.5 million in 2035. Brazil and Argentina offer a potentially favorable bovine-input context, while Mexico's broth traditions can reduce consumer unfamiliarity. The key commercial challenge is translating that cultural familiarity into an affordable, verified protein format within a supplement-led market. Local sourcing could improve the economics, but it must be matched with processing and quality capabilities.

Middle East & Africa

Middle East & Africa rises from USD 4.1 million in 2025 to USD 8.0 million in 2035. Gulf markets offer a premium wellness consumer base, but Halal status is an operational access requirement for animal-derived products, not a peripheral marketing claim. Taranaki Bio Extracts markets Halal-certified bovine ingredients, illustrating the type of supplier qualification that can support regional entry. Outside the Gulf, narrower distribution and purchasing-power constraints limit the pace at which premium bone broth products can scale.

For ingredient suppliers, the implication is especially clear: traceability and certification can be commercial enablers in Europe and the Gulf, while flexible formats and local partner capability may be more decisive in Asia Pacific and Latin America. Regional expansion should be paced to the operational readiness of the product, not merely to the forecast growth rate.

Bone Broth Protein Market Share & Competitive Landscape

The leading five companies account for 42.2% of 2025 market value: Ancient Brands holds 12.5%, The Campbell's Company 10.7%, Kettle & Fire 8.1%, Bare Bones 7.5%, and Bonafide Provisions 3.4%. The remaining market is fragmented across specialty brands, private-label offerings, and ingredient suppliers. This mix produces three competitive models: scaled packaged-food distribution, premium consumer brands built on sourcing and lifestyle relevance, and B2B ingredient providers that enable multiple finished-product brands.

Ancient Brands competes through a broad Bone Broth Protein portfolio and premium certification-oriented positioning. The Campbell's Company and Kitchen Basics offer scale and mass-market access. Kettle & Fire combines a premium broth proposition with broad distribution; its reported 2025 financing and new manufacturing facility indicate a move toward greater control of its supply chain and capacity. ^{[8]NOSH, Kettle & Fire Nets $43M from Colter Ventures, February 2025, nosh.com} Bare Bones and LonoLife emphasize convenience-oriented formats, while Bonafide Provisions, Bluebird Provisions, FOND Bone Broth, Organixx, and NOW Foods address premium, natural, or supplement-led use cases. FOND's regenerative certification claim is a differentiator in the provenance-led premium tier.

Essentia Proteins and Taranaki Bio Extracts operate differently from consumer brands. Their competitive position rests on ingredient specifications, supply reliability, and the ability to support food, beverage, and supplement formulations. Their role becomes more important as food and beverage applications expand, because a branded product's claims and sensory performance are partly determined upstream.

Competitive advantage is unlikely to come from animal source alone. Brands need a credible combination of composition verification, format fit, channel execution, and sourcing documentation. Companies with mass distribution can lower discovery barriers; premium specialists can protect pricing where provenance is demonstrated; and ingredient suppliers can capture value where they turn traceability and processing capability into repeatable customer solutions.

Recent Industry Developments

• February 2025 - Kettle & Fire received a $43 million investment from Colter Ventures. NOSH reported that the transaction was intended to support the company's next stage of growth and followed its expansion in branded broth distribution.
• 2025 - Kettle & Fire opened the KettleWorks facility in Lancaster, Pennsylvania. The company's first owned manufacturing site was positioned to increase control over production, quality, and product development.
• April 2025 - ConsumerLab published comparative bone-broth testing. The testing reported collagen-content variation across reviewed products, highlighting the competitive relevance of analytical verification and label accuracy.